NEW YORK, July 11, 2017 /PRNewswire/ -- Chronic Kidney Disease (CKD) Drugs Market (Drug Class - ACE Inhibitors, Angiotensin-II Receptor Blockers, Calcium Channel Blockers, Beta Blockers, Erythropoiesis - stimulating Agents (ESAs), and Diuretics; End User - Hospitals and Specialty Clinics)...
For more information, please visit
http://www.prnewswire.com/news-releases/[...]ast-2016---2024-300485856.html